These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12555335)

  • 1. [Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis].
    Niakara A; Nébié LV; Samadoulougou AK; Kaboré NJ; Ouandaogo BJ; Drabo YJ
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):113-7; discussion 118. PubMed ID: 12555335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative assessment of cibenzoline administration for vagally mediated paroxysmal atrial fibrillation using frequency-domain heart rate variability analysis.
    Miyakoshi M; Ikeda T; Miwa Y; Sakaki K; Ishiguro H; Abe A; Tsukada T; Mera H; Yusu S; Yoshino H
    J Cardiol; 2009 Aug; 54(1):86-92. PubMed ID: 19632526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of cibenzoline in the preventive treatment of recurrent atrial arrhythmia].
    Pisapia A; Bine-Scheck F; Schenowitz A; Domerego JJ; Maraud L; Canler A; Labban N; Viart R; Aubry P; Beruben E
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):143-51. PubMed ID: 7912916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Saito E; Kobayashi T; Okumura K
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the efficacy and tolerability of oral administration of cibenzoline in the prevention of recurrence of symptomatic atrial fibrillation].
    Medvedowsky JL; Bine-Scheck F; Dambrine P; Domerego JJ; Garnier LF; Labaki F; Piechaczyk P; Rouesnel P; Schenowitz A
    Ann Cardiol Angeiol (Paris); 1994 Feb; 43(2):89-96. PubMed ID: 8172484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
    Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cibenzoline intoxication: effect of combined hemoperfusion-hemodialysis on plasma clearance.
    Meeus R; Verpooten GA; De Paep R; Paelinck BP; Neels H; Cooreman S; De Doncker M; Jorens PG
    Clin Toxicol (Phila); 2008 Apr; 46(4):303-6. PubMed ID: 18363124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Abe N; Kameda K; Owada S; Tomita H; Oikawa K; Okumura K
    J Cardiol; 2003 Apr; 41(4):191-8. PubMed ID: 12728540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cibenzoline transforms random re-entry into ordered re-entry in the atria.
    Brugada J; Gürsoy S; Brugada P; Atié J; Guiraudon G; Andries E
    Eur Heart J; 1993 Feb; 14(2):267-72. PubMed ID: 8449204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of atrial fibrillation].
    Fazekas T; Csanádi Z; Varró A
    Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Too little, too late: chasing atrial fibrillation with sodium channel antagonists.
    Anderson ME
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):655-6. PubMed ID: 16836717
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug therapy for atrial fibrillation.
    Musco S; Conway EL; Kowey PR
    Med Clin North Am; 2008 Jan; 92(1):121-41, xi. PubMed ID: 18061001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation (the questions of etiology, classification, and treatment)].
    Gurevich MA
    Klin Med (Mosk); 2006; 84(2):7-15. PubMed ID: 16612998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation.
    Sloan RW; Zervanos NJ; Snyder RL; Zurad EG
    J Fam Pract; 1986 Jan; 22(1):25-7, 30-4, 36. PubMed ID: 3941299
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
    Aksnes TA; Flaa A; Strand A; Kjeldsen SE
    J Hypertens; 2007 Jan; 25(1):15-23. PubMed ID: 17143167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.